Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Statement re Possible Offer

9 Oct 2015 14:18

RNS Number : 8442B
Al Noor Hospitals Group PLC
09 October 2015
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE

 

FOR IMMEDIATE RELEASE

October 9th, 2015

 

The Board of Al Noor Hospitals Group Plc (the "Company") notes the recent media speculation in relation to the Company and confirms that it has received an approach from NMC Health Plc ("NMC") regarding a possible offer.

 

In accordance with Rule 2.6(a) of the Code, NMC is required, by not later than 5.00 p.m. on November 6th, 2015, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Code.

 

A copy of this announcement will be available at www.alnoorhospital.com/investors.

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Enquiries

Rothschild (lead financial adviser and co-sponsor)

Robert LeitãoHedley Goldberg

 

Tel: +44 207 280 5000

Goldman Sachs International (co-financial adviser and corporate broker)

Ben ThorpeNimesh Khiroya

 

Tel: +44 207 774 1000

Jefferies (corporate broker and co-sponsor)

Paul Nicholls

Henry Elphick

 

 

Tel: +44 207 029 8000

This announcement has been issued by and is the sole responsibility of the Company.

N M Rothschild & Sons Limited ("Rothschild"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Rothschild or for providing advice in relation to the matters set out in this announcement.

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Goldman Sachs International nor for providing advice in relation to the matters in this announcement. Neither Goldman Sachs International nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs International in connection with this announcement, any statement contained herein or otherwise.

Jefferies International Limited ("Jefferies"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Jefferies or for providing advice in relation to the matters set out in this announcement. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so would breach any applicable law.

 

Disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror

and Dealing Disclosures must also be made by the offeree company, by any offeror and by

any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening

Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure

Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of

the number of relevant securities in issue, when the offer period commenced and when any

offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44

(0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening

Position Disclosure or a Dealing Disclosure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDLLFLVISLAIIE
Date   Source Headline
13th Oct 201510:23 amBUSForm 8.3 - NMC Health Plc Amendment
13th Oct 20159:39 amBUSForm 8.3 - NMC Health Plc
12th Oct 20153:21 pmBUSForm 8.3 - NMC HEALTH PLC
12th Oct 20153:10 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:06 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:04 pmRNSForm 8.3 - Al Noor Hospitals Group Plc
12th Oct 20152:33 pmRNSForm 8.3 - NMC HEALTH GROUP PLC
12th Oct 20151:42 pmRNSBoard Change
12th Oct 201511:35 amRNSForm 8.5 (EPT/RI)
12th Oct 201510:37 amRNSForm 8.5 (EPT/RI)-NMC Health Plc
12th Oct 20157:00 amRNSRule 2.10 Announcement
9th Oct 20153:00 pmRNSNMC Health confirms a possible offer for Al Noor
9th Oct 20152:18 pmRNSStatement re Possible Offer
28th Sep 20157:00 amRNSDirector/PDMR Shareholding
9th Sep 20151:53 pmRNSDirector/PDMR Shareholding
26th Aug 20157:00 amRNSHalf Yearly Report
25th Aug 201510:48 amRNSClosing of ProVita acquisition
24th Aug 20153:41 pmRNSNMC Opens New Super Speciality Hospital in UAE
17th Aug 20151:22 pmRNSClosing Dr Sunny Healthcare Group acquisition
10th Aug 201510:28 amRNSNotification of Half Year Results
18th Jun 20154:35 pmRNSPrice Monitoring Extension
16th Jun 20155:04 pmRNSResults of voting at Annual General Meeting
15th Jun 20157:00 amRNSAcquisition of ProVita
4th Jun 20157:05 amRNSClosing of Americare Group acquisition
4th Jun 20157:00 amRNSAppointment of J.P.Morgan Cazenove
20th May 201511:30 amRNSDirector/PDMR Shareholding
20th May 20159:00 amRNSAGM and Dividend Timetable
29th Apr 20157:00 amRNSAcquisition
7th Apr 20151:39 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
30th Mar 20157:00 amRNSAppointment of FTI Consulting
30th Mar 20157:00 amRNSAppointment of HSBC as Joint Corporate Broker
26th Feb 20151:58 pmRNSDirector/PDMR Shareholding
26th Feb 201511:48 amRNSOptions grant award announcement
24th Feb 20157:02 amRNSAcquisition of Clinica Eugin
24th Feb 20157:00 amRNSFY 14 Results
16th Feb 20157:00 amRNSNew Financing Facility & Update to Group Strategy
30th Oct 20141:36 pmRNSNOTIFICATION MADE IN ACCORDANCE WITH RULE 3.1.4
28th Oct 20147:00 amRNSInterim Management Statement and Management Change
19th Aug 20147:00 amRNSHALF-YEARLY FINANCIAL REPORT
30th Jun 20141:00 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1)(a)
26th Jun 20144:09 pmRNSBoard Change
26th Jun 20144:07 pmRNSResults of voting at Annual General Meeting
26th Jun 201412:58 pmRNS2014 Half-Year pre-close statement
3rd Jun 20149:53 amRNSAGM and Proposed Board Changes
29th Apr 20147:00 amRNSInterim Management Statement
4th Apr 20144:12 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
26th Mar 201410:16 amRNSBoard Change
25th Feb 20141:16 pmRNSDividend Timetable and AGM notice
25th Feb 20147:02 amRNSDirectorate Change
25th Feb 20147:00 amRNSFull Year Results ending 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.